{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:19:33Z","timestamp":1791505173371,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejogrb.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T11:01:09Z","timestamp":1396436469000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions"],"prefix":"10.1016","volume":"177","author":[{"given":"Abdullah","family":"Tuten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezai","family":"Sahmay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Oncul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Serdar","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metehan","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel Cagin","family":"Gurleyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Levent","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.03.016_bib0005","first-page":"373","article-title":"Hirsutism in women","volume":"85","author":"Bode","year":"2012","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0029-7844(95)00065-Y","article-title":"Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome","volume":"85","author":"Carmina","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0020","first-page":"810","article-title":"Clinical review 56: nonclassic adrenal hyperplasia: current concepts","volume":"78","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0015-0282(16)54592-0","article-title":"Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia","volume":"56","author":"Levin","year":"1991","journal-title":"Fertil Steril"},{"issue":"Suppl B","key":"10.1016\/j.ejogrb.2014.03.016_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1096-6374(99)80074-4","article-title":"Transcription factors regulating pituitary development","volume":"9","author":"Parks","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0035","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-Mullerian hormone (AMH): what do we still need to know","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-Mullerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0050","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0055","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","article-title":"Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome","volume":"23","author":"Das","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0060","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03347408","article-title":"Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes","volume":"30","author":"Carmina","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0085","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0002-9378(80)90095-2","article-title":"Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease","volume":"138","author":"Lobo","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/jcem-69-3-577","article-title":"21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis","volume":"69","author":"Azziz","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0100","first-page":"635","article-title":"Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"74","author":"Feldman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","article-title":"The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"94","author":"Pall","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic\u2013pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0125","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis","volume":"67","author":"Fallat","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0135","series-title":"Proceedings of the Endocrine Society USA, 89th Annual Meeting","article-title":"Anti-M\u00fcllerian hormone (AMH) inhibits aromatase expression in granulosa cells from human ovaries","author":"Pellatt","year":"2007"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0145","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/dep074","article-title":"Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome","volume":"24","author":"Carlsen","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.1993.tb02419.x","article-title":"Clinical implications of hyperinsulinaemia in women","volume":"39","author":"Conway","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2014.03.016_bib0155","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:58Z","timestamp":1759555858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"alternative-id":["S0301211514001493"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.016","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}